131 related articles for article (PubMed ID: 16739868)
1. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients.
Tănăsescu R; Ticmeanu M; Nicolau A; Uscătescu V; Cojocaru M; Grecu V; Serbănescu A
Rom J Intern Med; 2005; 43(1-2):79-88. PubMed ID: 16739868
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke.
Cojocaru IM; Cojocaru M; Iacob SA
Rom J Intern Med; 2005; 43(1-2):89-95. PubMed ID: 16739869
[TBL] [Abstract][Full Text] [Related]
3. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
van Goor MP; Alblas CL; Leebeek FW; Koudstaal PJ; Dippel DW
Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465
[TBL] [Abstract][Full Text] [Related]
4. Anticardiolipin-antibodies in stroke and in other neurological disorders.
Perju-Dumbrava L; Zeiler K; Kapiotis S; Deecke L
Rom J Neurol Psychiatry; 1995; 33(2):137-43. PubMed ID: 7547377
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
6. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
7. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
[TBL] [Abstract][Full Text] [Related]
8. [Recurrence and prognosis in ischemic stroke patients with anticardiolipin antibody in Japan].
Kitagawa Y; Shinohara Y; Niwa K; Yoshitoshi M; Kametsu Y
Rinsho Shinkeigaku; 1994 Aug; 34(8):799-804. PubMed ID: 7994987
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antiphospholipid antibodies in young women with ischemic stroke.
Cojocaru IM; Cojocaru M; Burcin C; Atanasiu A
Rom J Intern Med; 2007; 45(2):201-4. PubMed ID: 18333375
[TBL] [Abstract][Full Text] [Related]
10. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
Ali HY; Abdullah ZA
J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
[TBL] [Abstract][Full Text] [Related]
11. IgG anti-cardiolipin antibodies-markers of inflammation in diabetic patients with ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
Rom J Intern Med; 2003; 41(3):277-81. PubMed ID: 15526511
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies as an independent risk factor for stroke in young Saudis.
Daif AK
Funct Neurol; 1998; 13(4):285-9. PubMed ID: 9934572
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
[TBL] [Abstract][Full Text] [Related]
14. [Anticardiolopin antibodies as a risk factor in stroke].
Krześniak-Bohdan M; Dobrzyńska L; Bakowska A; Banecka-Majkutewicz Z
Wiad Lek; 1998; 51(9-10):414-8. PubMed ID: 9921104
[TBL] [Abstract][Full Text] [Related]
15. [Ischemic stroke with antiphospholipid antibody].
Kitagawa Y; Ohkuma H; Tokuoka K
Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
[TBL] [Abstract][Full Text] [Related]
16. Study of antiphospholipid antibodies in patients treated with antiepileptic drugs.
Pardo A; González-Porque P; Gobernado JM; Jiménez-Escrig A; Lousa M
Neurologia; 2001 Jan; 16(1):7-10. PubMed ID: 11234666
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis.
Shahin AA; Mostafa H; Sami H; Shahin HA
Z Rheumatol; 2003 Jun; 62(3):246-50. PubMed ID: 12827401
[TBL] [Abstract][Full Text] [Related]
18. The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
Sebastian JK; Voetsch B; Stone JH; Romay-Penabad Z; Lo GH; Allen NB; Davis JC; Hoffman GS; McCune WJ; St Clair EW; Specks U; Spiera R; Loscalzo J; Pierangeli S; Merkel PA;
J Rheumatol; 2007 Dec; 34(12):2446-50. PubMed ID: 17918782
[TBL] [Abstract][Full Text] [Related]
19. High titer of anticardiolipin antibody is associated with first-ever ischemic stroke in Taiwan.
Lien LM; Chen WH; Chiu HC; Pan WH; Chen JR; Bai CH
Cerebrovasc Dis; 2006; 22(4):225-30. PubMed ID: 16788294
[TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
